About one third of BC patients, especially those with tumors positive for estrogen receptor expression (ER+), eventually develop a metastatic disease in distant organs, years after the diagnosis of the primary tumor, suggesting that the metastatic cells remain dormant for many years despite adjuvant therapy (6). The gene discussed is ESR1; the disease is metastatic neoplasm.